• 1
    Daniels G, Castilho L, Flegel WA, Fletcher A, Garratty G, Levene C, Lomas-Francis C, Moulds JM, Moulds JJ, Olsson ML, Overbeeke M, Poole J, Reid ME, Rouger P, Van Der Schoot E, Scott M, Sistonen P, Smart E, Storry JR, Tani Y, Yu L-C, Wendel S, Westhoff C, Yahalom V, Zelinski T: International society of blood transfusion committee on terminology for red cell surface antigens: macao report. Vox Sang 2009; 96:153156
  • 2
    Daniels GL, Fletcher A, Garratty G, Henry S, Jørgensen J, Judd WJ, Levene C, Lomas-Francis C, Moulds JJ, Moulds JM, Moulds M, Overbeeke M, Reid ME, Rouger P, Scott M, Sistonen P, Smart E, Tani Y, Wendel S, Zelinski T: Blood group terminology 2004. From the ISBT committee on terminology for red cell surface antigens. Vox Sang 2004; 87:304316
  • 3
    Thuresson B, Westman JS, Olsson ML: Genetic typing of the P1/P2 histo-blood groups made possible by identification of a novel A4GALT exon. Transfusion 2009; 49(Suppl.):48A (abstract)
  • 4
    Singleton BK, Burton NM, Green C, Brady RL, Anstee DJ: Mutations in EKLF/KLF1 form the molecular basis of the rare blood group In(Lu) phenotype. Blood 2008; 112:20812088
  • 5
    Singleton BK, Roxby D, Stirling J, Spring FA, Wilson C, Poole J, Anstee DJ: A novel GATA1 mutation (Ter414Arg) in a family with the rare X-linked blood group Lu(a−b−) phenotype. Blood 2009; 114:1979 (abstract)
  • 6
    Tilley L, Green C, Poole J, Gaskell A, Ridgwell K, Burton NM, Uchikawa M, Akkøk CA, Daniels G: A new blood group system, RHAG: three antigens resulting from amino acid substitutions in the Rh-associated glycoprotein. Vox Sang 2010; 98:151159
  • 7
    Bruce LJ, Beckmann R, Ribeiro ML, Peters LL, Chasis JA, Delaunay J, Mohandas N, Anstee DJ, Tanner MJ: A band 3-based macrocomplex of integral and peripheral proteins in the RBC membrane. Blood 2003; 101:41804188
  • 8
    Van Den Akker E, Satchwell TJ, Pellegrin S, Flatt JF, Maigre M, Daniels G, Delaunay J, Bruce LJ, Toye AM: Investigating the key membrane protein changes during in vitro erythropoiesis of protein 4.2 (−) cells (mutations Chartres 1 and 2). Haematologia 2010; in press
  • 9
    Salomao M, Zhang X, Yang Y, Lee S, Hartwig JH, Chasis JA, Mohandas N, An X: Protein 4.1R-dependent multiprotein complex: new insights into the structural organization of the red blood cell membrane. Proc Natl Acad Sci USA 2008; 105:80268031
  • 10
    Johnson RJ, Hillmen P: Paroxysmal nocturnal hemoglobinuria: nature’s gene therapy? Mol Pathol 2002; 55:145152
  • 11
    Luzzatto L: Paroxysmal nocturnal hemoglobinuria: an acquired X-linked genetic disease with somatic-cell mosaicism. Curr Opin Genet Dev 2006; 16:317322
  • 12
    Gargiulo L, Lastraioli S, Cerruti G, Serra M, Loiacono F, Zupo S, Luzzatto L, Notaro R: Highly homologous T-cell receptor beta sequences support a common target for autoreactive T cells in most patients with paroxysmal nocturnal hemoglobinuria. Blood 2007; 109:50365042
  • 13
    Ju T, Cummings RD: A unique molecular chaperone Cosmc required for activity of the mammalian core 1 beta3-galactosyltransferase. Proc Nat Acad Sci USA 2002; 99:1661316618
  • 14
    Karamatic Crew V, Singleton BK, Green C, Parsons SF, Daniels G, Anstee DJ: New mutations in C1GALT1C1 in individuals with Tn positive phenotype. Br J Haematol 2008; 142:657667